Substantial activity of thalidomide in multiple myeloma, study shows

被引:0
|
作者
不详
机构
来源
ONCOLOGY-NEW YORK | 2000年 / 14卷 / 03期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:452 / 452
页数:1
相关论文
共 50 条
  • [31] Thalidomide and thrombosis in patients with multiple myeloma
    Camba, L
    Peccatori, J
    Pescarollo, A
    Tresoldi, M
    Corradini, P
    Bregni, M
    HAEMATOLOGICA, 2001, 86 (10) : 1108 - 1109
  • [32] Introduction: Thalidomide and the IMiDs in multiple myeloma
    Barlogie, B
    SEMINARS IN HEMATOLOGY, 2003, 40 (04) : 1 - 2
  • [33] Thalidomide: results in multiple myeloma and lupus
    Martinez-Callejo, V.
    de la Paz, A. Garcia
    Uranga, A. Illaro
    Gosalbez, J. R. Ferrandiz
    PHARMACY WORLD & SCIENCE, 2008, 30 (06): : 1022 - 1022
  • [34] Thalidomide and dexamethasone for resistant multiple myeloma
    Anagnostopoulos, A
    Weber, D
    Rankin, K
    Delasalle, K
    Alexanian, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (05) : 768 - 771
  • [35] Therapeutic application of thalidomide in multiple myeloma
    Kyle, RA
    Rajkumar, SV
    SEMINARS IN ONCOLOGY, 2001, 28 (06) : 583 - 587
  • [36] Thalidomide in elderly patients with multiple myeloma
    Kusumi, Eiji
    Matsumura, Tomoko
    Yuji, Koichiro
    Tanaka, Yuji
    Kami, Masahiro
    LANCET, 2006, 367 (9527): : 1977 - 1977
  • [37] Desensitization to thalidomide in a patient with multiple myeloma
    Nucera, Eleonora
    Schiavino, Domenico
    Hohaus, Stefan
    Leone, Giuseppe
    Buonomo, Alessandro
    Lombardo, Carla
    Patriarca, Giampiero
    CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (03): : 176 - 178
  • [38] Thalidomide in IgA multiple myeloma.
    Lim, SH
    Maclean, R
    BLOOD, 1998, 92 (10) : 279B - 279B
  • [39] Thalidomide: present and future in multiple myeloma
    Hussein, MA
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (01) : 25 - 31
  • [40] Thalidomide as a targeted therapy for multiple myeloma
    Dan, K
    INTERNAL MEDICINE, 2003, 42 (07) : 550 - 551